Richard Hammond - Penrhosbio

Health Canada approve Remora™ technology in two medical devices.

Post Author:Richard Hammond
Post published:June 20, 2023
Post Category:Uncategorized

Working with our dental partners Pro3dure Medical, our anti biofilm platform (Remora™) has been incorporated into two of their key medical devices using their MSI® (Multi Species Inhibition) technology. We…

Penrhos Bio signs license for 3D printed hearing aids

Post Author:Richard Hammond
Post published:April 25, 2023
Post Category:Uncategorized

Penrhos Bio joins with Pro3dure™ in a milestone licence deal that will bring the Remora™ technology into the dental space in 3D printed materials...

First product launched with Remora® technology to control harmful biofilms at IDS dental trade fare, Germany

Post Author:Richard Hammond
Post published:March 15, 2023
Post Category:Uncategorized

Penrhos Bio joins with Pro3dure™ in a milestone licence deal that will bring the Remora™ technology into the dental space in 3D printed materials...

Health Canada approve Remora™ technology in two medical devices.

Penrhos Bio signs license for 3D printed hearing aids

First product launched with Remora® technology to control harmful biofilms at IDS dental trade fare, Germany

© Copyright Penrhos Bio 2020

© Copyright Penrhos Bio 2023